Test Price
2,800 AED✅ Home Collection Available
FLNA Gene Neuronal Intestinal Pseudo-obstruction Genetic Test in UAE – DNA Labs UAE
Executive Summary & Core Metrics
🔬 Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139) at DNA Labs UAE.
🏥 Premium Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM daily).
🧬 Clinical Guidance
Telephonic Post-Test Genetic Counselling to interpret results within clinical context.
💳 Insurance Verification
Direct Billing Inquiry via WhatsApp: +971 54 548 8731
Corporate Lab
DNA Labs UAE – DHA Facility License No. 1143. Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Test Overview & Methodology
The FLNA gene test utilizes next‑generation sequencing (NGS) on the Illumina platform to detect pathogenic variants associated with neuronal intestinal pseudo‑obstruction. This comprehensive analysis includes whole gene sequencing and copy‑number variant (CNV) detection, delivering a diagnostic sensitivity exceeding 99.9% including deep intronic and structural variants.
| Feature | Our Genetic Test (NGS+CNV) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Method | Whole gene NGS + CNV analysis (Illumina platform) | Targeted exon‑by‑exon Sanger sequencing |
| Diagnostic Sensitivity | >99.9% (including deep intronic & structural variants) | ~95% (misses large rearrangements) |
| Turnaround Time | 3 – 4 weeks | 4 – 6 weeks |
| Cost (AED) | 2,800 (all-inclusive) | Often >3,000 (limited insurance coverage) |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics practicing in Dubai Healthcare City, I recognize the diagnostic uncertainty that often accompanies chronic intestinal dysmotility. A definitive FLNA mutation result transforms ambiguity into a precise molecular diagnosis, enabling early multidisciplinary management and informed family counseling. Genetic results must always be interpreted in conjunction with the referring physician—never self‑adjust treatment based solely on a report.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Reg. ID: 9294403
Medication Advisory
⚠️ Do not discontinue any prescribed medication without consulting your physician. This genetic test does not replace clinical evaluation or current treatment plans.
Exclusion Criteria & Safety Red Flags
- Exclusion: Recent allogeneic hematopoietic stem cell transplant (within 12 months) may yield donor‑derived DNA, not representative of the patient’s germline.
- Exclusion: Inability to provide a blood sample or FTA card due to severe phlebotomy contraindication (e.g., critical illness, extreme venous fragility).
- ER Red Flags: Acute onset of severe abdominal distension, vomiting, obstipation, or signs of complete bowel obstruction require immediate emergency medical evaluation — do not wait for genetic test results.
- ER Red Flags: Unexplained high fever with abdominal signs should prompt urgent care to rule out perforation or peritonitis.
Patient FAQ & Clinical Guidance
1. What is the purpose of the FLNA gene test?
This test detects disease‑causing FLNA gene variants associated with neuronal intestinal pseudo‑obstruction, confirming a molecular diagnosis and informing family screening. It is a definitive step after clinical suspicion and can help differentiate type of chronic intestinal pseudo‑obstruction for surgical or pregnancy planning.
2. How is the sample collected for this test?
Our certified phlebotomists collect a peripheral blood sample at your home using temperature‑controlled cold‑chain transport, or you can submit a DNA FTA card as an alternative. Both methods ensure high‑integrity genetic material for next‑generation sequencing.
3. When will I receive my results and how are they interpreted?
Results are typically available in 3–4 weeks, and our genetic counsellor will explain the findings during a phone consultation to ensure clear understanding. We deliver a comprehensive report with clinically actionable recommendations for your referring physician.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly complies with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – safeguarding patient genetic information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure digital health data handling.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – governing clinical testing safety and patient consent.
- ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) – quality management system.
- DHA Facility License No. 1143 – operating from Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | FLNA Gene Neuronal Intestinal Pseudo‑obstruction Genetic Test (NGS + CNV) |
| Price (AED) | 2,800 (all‑inclusive, no hidden fees) |
| Turnaround Time | 3 – 4 weeks from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or DNA FTA card; VIP Mobile Phlebotomy & Cold‑Chain Home Collection available daily 8 AM – 11 PM |
| Methodology Used | Next‑Generation Sequencing (Illumina) with CNV analysis |
| ICD‑10‑CM Code | K59.8, Q04.5, Z13.79 |
| LOINC Code | 101411‑5 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians